Hospitalization and rehospitalization for acute coronary syndromes significantly contribute to the rising annual cost of healthcare. Despite growing evidence of the effectiveness of early and aggressive treatment of cardiovascular risk factors at the time of an acute event, eligible individuals are still not receiving adequate therapy. Inclusion of appropriate coronary artery disease treatments including lipid-lowering therapy at the time of hospitalization can lead to increased long-term compliance and reduced morbidity and mortality.
No takes yet. Share an insight, caveat, or question.
Polk et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: